Niga-ichigoside F1, an orally active ursane triterpenoid, has antihyperlipidemic and antioxidant activities. Niga-ichigoside F1 can prevent high-fat diet (HFD)-induced hepatic steatosis.
In Vitro
Niga-ichigoside F1 (2.5, 5, 10, 20 μM; for 24 hours) inhibits lipid accumu-lation in free fatty acid (FFA)-treated HepG2 cells in a dose-dependent manner. Niga-ichigoside F1 has no effects on cell viability. Both nuclear and cytoplasmic Nrf2 expressions are lowered in Con, Niga-ichigoside F1 (20 μM), FFA (1 mM), and Niga-ichigoside F1 plus FFA treated Nrf2-silenced cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Niga-ichigoside F1 (40 mg/kg; oral gavage; for 12 weeks) alleviates hepatic steatosis, possibly by significantly interacting with high-fat diet (HFD) to regulate lipid metabolism genes (including Srebp1c, Acc1, Fasn, Scd1, Cpt1a and Fabp5) in four-week-old male C57BL/6J mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
规格
别名
黑草莓苷F1
英文别名
CHEBI:67917 | AKOS040760595 | nigaichigoside F1 | Niga-ichigoside F1 | 19alpha-hydroxyasiatic acid-28-O-beta-D-glucopyrannoside | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-1,10,11-trihy
规格或纯度
≥99%
英文名称
Niga-ichigoside F1
生化机理
Niga-ichigoside F1是一种具有口服活性的熊果烷三萜类化合物,具有抗高血脂和抗氧化活性。Niga-ichigoside F1 可以预防高脂饮食(HFD)引起的肝脏脂肪变性。